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Background: Radiation absorbed by interventional cardiologists is a frequently under-evaluated important
issue. Aim is to compare radiation dose absorbed by interventional cardiologists during percutaneous
coronary procedures for acute coronary syndromes comparing transradial and transfemoral access.
Methods: The randomized multicentre MATRIX (Minimizing Adverse Haemorrhagic Events by TRansradial
Access Site and Systemic Implementation of angioX) trial has been designed to compare the clinical outcome
of patients with acute coronary syndromes treated invasively according to the access site (transfemoral vs.
transradial) and to the anticoagulant therapy (bivalirudin vs. heparin). Selected experienced interventional
cardiologists involved in this study have been equipped with dedicated thermoluminescent dosimeters to
evaluate the radiation dose absorbed during transfemoral or right transradial or left transradial access. For
each access we evaluate the radiation dose absorbed at wrist, at thorax and at eye level. Consequently the
operator is equipped with three sets (transfemoral, right transradial or left transradial access) of three
different dosimeters (wrist, thorax and eye dosimeter). Primary end-point of the study is the procedural
radiation dose absorbed by operators at thorax. An important secondary end-point is the procedural radiation
dose absorbed by operators comparing the right or left radial approach. Patient randomization is performed
according to the MATRIX protocol for the femoral or radial approach. A further randomization for the radial
approach is performed to compare right and left transradial access.
Conclusions: The RAD-MATRIX study will probably consent to clarify the radiation issue for
interventional cardiologist comparing transradial and transfemoral access in the setting of acute coronary
syndromes.
© 2014 Elsevier Inc. All rights reserved.ndroPertiniHospital - ASLRMB,
81.
A. Sciahbasi).1. Introduction
Interventional cardiologists are routinely and chronically ex-
posed to ionizing radiations that are necessary to perform diagnostic
and interventional coronary procedures. Moreover, some reports
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cardiologists is the greatest registered by any medical staff exposed
to X-rays [1,2].
Even if radioprotection is an important issue for operators due to
the long term stochastic risk of radio-induced cancer [3], this issue is
often under evaluated.
1.1. Radiation risk for interventional cardiologists
Generally the stochastic risk related to radiation is an all-or-none
phenomenon for any individual cell, but the greater the radiation
exposure, the bigger number of injured cells [4]. Other than cancerous
effects, such as cataract formation, were found to be statistically
related to radio-exposure [5]. In a recent study [6] an increased risk for
brain and neck tumours has been observed among physicians
performing interventional procedures. Consequently, operators
should apply all efforts to reduce their exposition to radiation dose
according to the ALARA principle [3]: operators should maintain
radiation exposure at a level that is “As Low As Reasonably
Achievable”, limiting the duration of exposure, increasing the distance
from the radiation source and implementing the shielding equipment.
Radiation dose can be expressed in different ways: the Air Kerma is
the amount of energy absorbed in a given mass of air, whereas the
dose area product (DAP) is the absorbed dose of radiation across a
given surface area. Generally DAP measurements are more accurate
than using Air Kerma measurements for the estimation of patient
radiation dose as DAP allows for variations in field size [7]. DAP
consents a good estimation of the dose to the irradiated tissue and is
an indicator for patient cancer risk. Differently Sievert is the unit used
to express the biological damage to human tissues [8] and to evaluate
the radiation dose absorbed by operators.
1.2. Transradial approach and clinical outcome
The number of percutaneous diagnostic and interventional
percutaneous coronary procedures performed through transradial
approach is progressively increasingworldwide [9]. Themany reasons
for this “radial boom” include a reduction in vascular complicationsTable 1
Patient radiation dose in studies comparing transradial and transfemoral access.
Author (year) Femoral (n) Radial (n) Design Procedure Right access
Shah (2013) 870 240 Retr Cor 85
Shah (2013) 512 74 Retr PCI 89
Delewi (2013) 2950 6614 Prosp Cor NA
Delewi (2013) 2792 5056 Prosp PCI NA
Michael (2013) 63 63 Rand Cor 0
Michael (2013) 30 24 Rand PCI 0
Rigattieri (2013) 243 1153 Retr Cor + PCI 82
Jolly (2013) 2255 Rand Cor + PCI NA
Lo (2012) Senior 25 25 Prosp Cor 100
Lo (2012) Trainee 25 25 Prosp Cor 100
Hibbert (2012) 361 203 Retr Cor + PCI NA
Mercuri (2011) 4190 1764 Prosp Cor + PCI NA
Lehmann (2010) 842 624 Prosp Cor + PCI 100
Brueck (2009) 512 512 Rand Cor + PCI NA
Achenbach (2008) 155 152 Rand Cor + PCI 92
Lange (2006) 103 92 Rand Cor 100
Lange (2006) 48 54 Rand PCI 100
Sandborg (2004) 40 36 Prosp Cor NA
Sandborg (2004) 42 24 Prosp PCI NA
Geijer (2004) 114 55 Posp Cor + PCI 98
Larrazet (2003) 184 218 Prosp PCI NA
DAP (Gycm2) and AK (mGy) results are expressed as median.
AK: air kerma; Cor: diagnostic coronarography; DAP: dose area product; NA: not availab
Retr: retrospective.
⁎ Results are expressed as mean.
† Data are available for 1445 patients.
¶ Results are expressed as mean logarithmically transformed air kerma.[10,11] and a better patient comfort [12,13] compared to transfemoral
approach. Moreover there is now a growing body of evidence that
transradial approach might be associated with a better outcome in
patients with acute coronary syndromes. The RIVAL [14] and the
RIFLE-STEACS [15] trials are two randomized studies that showed a
significant reduction in mortality with the transradial compared to
transfemoral access in patients with acute ST elevation myocardial
infarction. Also in non-ST elevation myocardial infarction there is a
possible advantage in terms of better outcome for transradial
approach even if data are conflicting. Indeed a better outcome
associated with transradial approach in this subset of patients was
shown in some observational studies [16] although it was not
confirmed in the RIVAL study [14]. The MATRIX trial and possibly
other randomized studies will clarify this issue.
1.3. Radiation exposure according to vascular access
Despite multiple advantages of transradial approach, a possible
drawback of this access is a higher radiation exposure compared to
transfemoral approach. The radiation risk might be increased both for
the physician and for the patient even if data are conflicting [17–31].
Most of the studies evaluated only the radiation dose absorbed by
patients and expressed it as DAP or Air Kerma (Table 1): some studies
showed a significant increase in radiation dose for transradial
compared to transfemoral approach, other studies showed no
differences between the two approaches while in few studies a
lower radiation dose for transradial approach was observed. The
major bias of these studies is the observational design of the vast
majority with only a few being randomized. To correct for the
potential procedural biases, some authors performed a multivariate
analysis [19,24,29,30], and in only one case the transradial approach
was an independent predictor of increased radiation dose [29].
Another limitation of these studies is that most have assessed the
fluoroscopy times, the DAP or the Air Kerma, that are only indirect
measures of the radiation dose absorbed by operators. Only few
studies [18,21,26,27,32] used dedicated operators' dosimeters and
evaluated the radiation dose directly absorbed by operators when
using different vascular accesses (Table 2). The majority of these(%) DAP femoral DAP radial P AK femoral AK radial P
50.19 60.40 0.003 670.3 805.4 0.02
153.95 196.49 0.02 2239 2795 0.03
31 31 0.18 NA NA -
79 73 b0.001 NA NA -
NA NA - ⁎1080 ⁎1290 0.06
NA NA - ⁎1560 ⁎1190 0.18
96.70 76.35 0.002 NA NA -
51 53 0.828 †930 †1046 0.051
⁎22.4 ⁎21.7 0.74 NA NA -
⁎25.2 ⁎25.4 0.90 NA NA -
⁎123.3 194.1 b0.001 NA NA -
NA NA - ¶6.28 ¶6.49 b0.001
13.38 15.76 0.149 NA NA -
38.2 41.9 0.034 NA NA -
⁎3.199 ⁎3.737 0.13 NA NA -
⁎13.1 ⁎15.1 b 0.05 NA NA -
⁎51 ⁎46.3 NS NA NA -
33 45 0.0026 NA NA -
40 69 0.013 NA NA -
54 51.9 NS NA NA -
175 138 b0.001 NA NA -
le; PCI: percutaneous coronary intervention; Prosp: prospective; Rand: randomized;
Table 2
Operator radiation dose in studies comparing transradial and transfemoral access.
Author (year) Femoral (n) Radial (n) Design Procedure Right access (%) Dose femoral Dose radial P Site
Michael (2013) 63 63 Rand Cor 0 13 ± 10 26 ± 17 b0.01 Breast pocket
Michael (2013) 30 24 Rand PCI 0 8.1 ± 7.1 13.9 ± 17.6 0.25 Breast pocket
Lo (2012) Senior 25 25 Prosp Cor 100 6.1 ± 5.6 6.4 ± 4.7 0.85 Left clavicle
Lo (2012) Trainee 25 25 Prosp Cor 100 8.8 ± 4.3 8.5 ± 6.5 0.86 Left clavicle
Brasselet (2008) 98 150 Prosp Cor NA ⁎13 (1–164) ⁎29 (1–195) b0.001 Left arm
Brasselet (2008) 83 90 Retr Cor + PCI NA ⁎41 (2–360) ⁎69.5 (4–531) b0.018 Left arm
Lange (2006) 103 92 Rand Cor 100 32 ± 39 64 ± 55 b 0.001 Breast pocket
Lange (2006) 48 54 Rand PCI 100 110 ± 115 166 ± 188 b0.05 Breast pocket
Sandborg (2004) 13 9 Prosp Cor + PCI NA 55 170 b0.01 Finger
Dose nμSv) results are expressed as mean.
Cor: diagnostic coronarography; NA: not available; PCI: percutaneous coronary intervention; Prosp: prospective; Rand: randomized.
⁎ Results are expressed as median with interquartile range.
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transradial compared to transfemoral access, although most data
come from non randomized studies.
The main reasons for the possible higher radiation dose during
transradial access are probably related to the more complicated
catheter manipulation requiring prolonged fluoroscopy time and to
the more unfavourable operator position, closer to X-ray source,
especially for less skilled operators. These difficulties are easily
overcome increasing the “radial competence” [33], but the magni-
tude of radiation exposure during transradial compared to transfe-
moral access for operators experienced in transradial approach is
still unclear.
Afinal issue for the radiation dose in transradial approach is the “side
arm effect”. Most of the studies evaluating the operator and patient
radiation dose during transradial and transfemoral percutaneous
coronary procedures were performed using the right radial access.
However in at least three previous studies [34–36], the left transradial
approach compared to the right access was associated with reduced
radiation dose for operators. The reason of this possible reduction in
radiation dose is unknown until now even if a possible explanation
might be a modest but significant reduction in fluoroscopy time [37].
At present there is only one study [18] comparing the left radial
approach with the femoral access in terms of radiation dose absorbed
either by the patients or by the operators. In this study a higher
radiation dose for left radial compared to transfemoral approach has
been observed, but this study has been performed only in patients
with previous coronary artery by-pass.
1.4. Aim and end-points of the study
Aim of our study is to evaluate the radiation dose absorbed by
operators during percutaneous coronary procedures in the setting of
acute coronary syndromes comparing the transradial and the
transfemoral approach. The radiation exposure during right or left
transradial procedures is also compared.
The primary end-point of the study is the procedural radiation
dose absorbed by operators and detected by thermo luminescent
dosimeters placed at thorax level of the operators. Key secondary end-
points are the procedural radiation dose measured at the operator's
wrist and eye. Other secondary end-points are the radiation dose
normalized by DAP and by fluoroscopy time, fluoroscopy times and
DAP values.
1.5. Study design and population
The MATRIX (Minimizing Adverse Haemorrhagic Events by
TRansradial Access Site and Systemic Implementation of angioX)
trial (NCT01433627) has been designed to compare the clinical
outcome of patients with acute coronary syndromes treated inva-
sively according to the access site (transfemoral vs. transradial) and tothe anticoagulant therapy (bivalirudin vs. heparin). It is a large-scale,
multicenter, prospective, open-label trial, conducted at approximately
100 sites in Europe in centers performing either transradial and
transfemoral approach for percutaneous coronary procedures andwill
enrol more than 8,000 patients.
All diagnostic or interventional procedures performed in selected
centers by operators involved in the MATRIX trial are included in this
sub-study without exclusion criteria. The operator and center
selection is performed according to the operator experience and to
the recruiting volume: only highly experienced operators and high
volume recruiting centers are included in this substudy. Moreover in
the operators' selection for our sub-study, we also required that
operators can perform equally right or left transradial access.
Operator radiation exposure is assessed using three sets of three
dedicated dosimeters for the femoral approach, for the right radial
approach and for the left radial approach.
Effective doses delivered to patients are expressed as DAP and
measured in Gycm2. The DAP is directly measured by the collimator of
the angiographic system. The duration of the procedure is expressed
in minutes of fluoroscopy time.
1.6. Dosimeters description
The study uses lithium fluoride thermo luminescent dosimeters
with a range of linearity from 1 μGy to 10 Gy. All dosimeters,
contained in a plastic package for water and dust risk, are easy to wear
and do not interfere with operator comfort during the procedures. In
order to facilitate delivery and collection of data, dosimeter's label
clearly indicate operator's code, access site (femoral, right or left
radial) and body destination (eye, throax or wrist) (Fig. 1). The
dosimeter's design is different according to it placement:
1. Thorax dosimeter: this dosimeter consists of a case (badge)
containing two thermoluminescent detectors under two filter of
various materials in a symmetrical configuration, so it can be worn
in each side. The thorax dosimeter is placed in the breast pocket
outside the lead apron.
2. Wrist dosimeters: dosimeters for the wrist weigh less than 2 grams
and can be incorporated in a waterproof flexible package and worn
under surgical gloves (Fig. 1).
3. Eye dosimeter: this dosimeter contains three different filters, have
a weight b 3 grams and is placed on the head cup (Fig. 1).
According to the randomization of theMATRIX trial, operators locate
the three dosimeters on the left wrist, at mid thorax level, in the breast
pocket outside the lead apron and at eye level outside the lead glasses
(Fig. 2). At the end of the study the dosimeters will be send to
TECNORAD co. (Verona, Italy) to measure the radiation dose absorbed
by operators. The radiation dose obtained for each dosimeter is then
divided for the number of procedures in whom the dosimeter has been
employed in order to obtain the mean radiation dose per procedure.
Fig. 1. Three different dosimeters are employed: wrist dosimeter (A), eye dosimeter (B) and thorax dosimeter (C). Each dosimeter is labelled with the site access (arrow), the
operator code (square) and with the body destination (circle).
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Patient randomization is performed according to the MATRIX
protocol for the femoral or radial approach using aWeb-based system.
A further randomization for the radial approach is performedFig. 2. Placement of the three dosimeters. The operator is equipped with three
dosimeters per access: one dosimeter is placed at left wrist, another is fixed at the
breast pocket and the third on the head cup close to the eye.according to the identification (ID) number of patient: odd ID
numbers are assigned to right radial whereas even ID numbers are
assigned to left radial access. The data analysis will be performed as
“intention to treat,” and consequently operators do not need to
remove their dosimeters if they need to switch from transradial to
transfemoral approach or vice versa. Considering that only highly
experienced operators are involved in this sub-study we will expect a
very low rate of cross over from one to the other vascular access.
The sample size was estimated on the basis of the primary end-
point (procedural radiation dose absorbed at thorax by operators
comparing transradial vs. transfemoral approach). The primary non
inferiority hypothesis of this study is that the radial approach does not
cause an increase of radiation dose to the operator compared to
transfemoral approach. Considering that our dosimeters measure the
cumulative radiation dose, the sample size is calculated for the
number of dosimeters needed rather than for the number of
procedures. Moreover to avoid potential procedural biases (for
example balancing long vs. short procedures), each dosimeter should
be used in at least 12 procedures per access. According to a previous
study evaluating the thorax operator radiation dose for transradial
compared to transfemoral approach [26], showing a procedural mean
dose of 142 microSievert for a single percutaneous coronary
diagnostic plus interventional procedure through transfemoral ap-
proach we determined that 26 dosimeters (13 per access) would
provide a power of 80% to calculate a non inferiority margin of 25
microSievert (18% difference) with a one-sided alpha level of 0.05.
Since each set of dosimeters will be used in at least 12 patients a
minimum of 312 patients will be enrolled in the present study.
1.8. Percutaneous coronary procedure
The coronary procedure is performed according to the MATRIX
protocol and according to the standard of each operator involved in
the study: the sheath selection (long vs. short, hydrophilic vs. non
hydrophilic), the catheter curve employed and the use of adjunctive
213A. Sciahbasi et al. / Cardiovascular Revascularization Medicine 15 (2014) 209–213tools (manual thrombus-aspiration, intracoronary ultrasound) is left
to the operator's choice.
Standard operator radio-protection in all procedures is ensured
using a lead apron (two layers of 0.25 mm lead equating to 0.5 mm in
the front of the operator), a thyroid lead collar, leaded glasses (0.5 mm
leaded-equivalent for each), under-table leaded flaps attached to the
table, and an upper mobile leaded glass suspended from the ceiling.
2. Conclusions
Considering the controversial data on transradial and transfemoral
approach in terms of radiation dose absorbed by interventional
cardiologists, the RAD-MATRIX study will give more detailed
information on this issue, collecting data on radiation exposure at
various parts of the body.
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